<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04187807</url>
  </required_header>
  <id_info>
    <org_study_id>UAutonomaSLP</org_study_id>
    <nct_id>NCT04187807</nct_id>
  </id_info>
  <brief_title>Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department</brief_title>
  <official_title>Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Autonoma de San Luis Potosí</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Autonoma de San Luis Potosí</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the efficacy of melatonin 5mg in the prevention of Delirium in the older
      adults in emergency department. Half of the participants will receive melatonin 5mg and the
      other half will use a starch-based placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Melatonia is useful for the treatment of sleep disorders due to the interruption of the
      circadian rhythm, secondary to alterations caused by the environment. The doses of 5 to 10mg
      oral or sublingual can improve the quality of the sleep-wake cycle and alertness in
      short-term use.

      Mechanism of action of melatonin are:

        1. Binding to membrane receptors: MT1 and MT2 coupled to G protein

        2. - Union to nuclear receptors.

        3. - Interaction with cytosolic proteins.

        4. - Antioxidant of direct and indirect action.

        5. - Interaction with mitochondria.

      Melatonin circulates 80% bound to albumin and the rest in free form in plasma, 85-90% is
      metabolized by 6-hydroxymelatonin in the liver, which is then conjugated with sulfuric acid
      (70-80%) or glucuronic ( 5-3%), and is excreted in urine and feces.

      Melatonin and its metabolites act as catalytic antioxidants to safeguard mitochondrial
      electron transfer reactions, therefore, increases the efficiency of energy metabolism.
      Melatonin synthesis decreases significantly as age progresses and changes in the circadian
      cycle have been associated with accelerated aging.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 10, 2019</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignament</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delirium</measure>
    <time_frame>14 days</time_frame>
    <description>Diagnosis based Confusional Assessment Method Scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">145</enrollment>
  <condition>Delirium in Old Age</condition>
  <arm_group>
    <arm_group_label>Melatonin 5mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Melatonin 5mg, every 24 hours for 14 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Starch based placebo, every 24 hours for 14 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin 5 mg</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Melatonin 5mg</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Cronocaps</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women over 60 who enter the emergency department with a stay in the ward for
             more than 8 hours and who will remain hospitalized for more than 48 hours due to
             admission pathology.

          -  Patients who agree to participate in the study by signing an informed consent
             (Signature by patient and / or family member).

        Exclusion Criteria:

          -  Patients with a history of dementia or previous neurological diseases.

          -  Patients with a history of psychiatric disorder.

          -  Patients diagnosed with any type of liver disease.

          -  Warfarin treatment.

          -  Delirium data on admission to the emergency department.

          -  Patients under invasive mechanical ventilation and sedation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Gordillo, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidad Autonoma de San Luis Potosí</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fatima A Sánchez, Doctor of medicine</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Autonoma de San Luis Potosí</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fatima A Sánchez, Doctor of medicinen</last_name>
    <phone>4441777616</phone>
    <email>alon118@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antonio Gordillo, PhD</last_name>
    <phone>4448262346</phone>
    <phone_ext>6688</phone_ext>
    <email>gordillo@uaslp.mx</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Mexicano Del Seguro Social</name>
      <address>
        <city>San Luis Potosí</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Ruíz, Doctor of medicine</last_name>
      <phone>4448216363</phone>
      <email>betoruizm74@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 3, 2019</study_first_submitted>
  <study_first_submitted_qc>December 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2019</study_first_posted>
  <last_update_submitted>December 4, 2019</last_update_submitted>
  <last_update_submitted_qc>December 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Autonoma de San Luis Potosí</investigator_affiliation>
    <investigator_full_name>Fátima Alondra Sánchez Martínez</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

